Patents by Inventor Mu-Yong Kim

Mu-Yong Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VEHICLE SEAT REINFORCEMENT DEVICE
    Publication number: 20240083384
    Abstract: A vehicle seat reinforcement device includes a leg portion mounted on a floor panel, a seat cushion frame slidably mounted on the leg portion, and a load reinforcing structure connected between the leg portion and the seat cushion frame, wherein when a seat belt anchorage load is transferred to the seat cushion frame, the seat cushion frame is locked to the leg portion by the load reinforcing structure.
    Type: Application
    Filed: February 3, 2023
    Publication date: March 14, 2024
    Applicants: Hyundai Motor Company, Kia Corporation, Daechang Seat Co.,LTD-Dongtan, Hyundai Transys Inc.
    Inventors: Sang Soo LEE, Chan Ho JUNG, Mu Young KIM, Sang Hark LEE, Ho Suk JUNG, Deok Soo LIM, Sang Do PARK, In Sun BAEK, Sin Chan YANG, Chan Ki CHO, Myung Soo LEE, Jae Yong JANG, Jun Sik HWANG, Ho Sung KANG, Hae Dong KWAK, Hyun Tak KO
  • Method of treating bacterial infections using gemifloxacin or a salt thereof and a ?-lactam antibiotic
    Patent number: 7169792
    Abstract: The present invention relates to a method of treating anti-bacterial infections which method comprises the separate, simultaneous or sequential administration to a patient in need thereof, of an effective amount of gemifloxacin or a salt thereof and a ?-lactam antibiotic.
    Type: Grant
    Filed: November 29, 2002
    Date of Patent: January 30, 2007
    Assignee: LG Life Sciences Ltd.
    Inventors: Nancy Niconovich, Stephen Rittenhouse, Lynn McCloskey, Kyong-Sook Paek, Mu-Yong Kim, Ha-Sik Youn
  • Method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent
    Publication number: 20050020567
    Abstract: The present invention relates to a method of treating anti-bacterial infections which method comprises the separate, simultaneous or sequential administration to a patient in need thereof, of an effective amount of gemifloxacin or a salt thereof and a carbapenem antibacterial.
    Type: Application
    Filed: November 29, 2002
    Publication date: January 27, 2005
    Inventors: Nancy Niconovich, Stephen Rittenhouse, Lynn McCloskey, Kyong-Sook Paek, Mu-Yong Kim
  • Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof
    Patent number: 5840916
    Abstract: The present invention relates to a novel quinolone compound having an excellent antibacterial activity. More specifically the present invention relates to a novel quinoline(naphthyridine)carboxylic acid derivative represented by the following formula (I), which has an 4-aminomethyl-3-oximepyrrolidine substituent on 7-position of the quinolone nucleus and shows a superior antibacterial activity in contrast to the known quinolone antibactrial agents having a weak activity against gram-positive bacterial strains and also has a broad antibacterial spectrum and a highly improved pharmacokinetic property ##STR1## wherein R, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and Q are defined as described in the specification.
    Type: Grant
    Filed: April 4, 1997
    Date of Patent: November 24, 1998
    Assignee: LG Chemical Ltd.
    Inventors: Chang Yong Hong, Young Kwan Kim, Jay Hyok Chang, Se Ho Kim, Hoon Choi, Do Hyun Nam, Jin-Hwan Kwak, Yi Na Jeong, Jeong In Oh, Mu Yong Kim
  • Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime)pyrrolidine substituent and processes for preparing thereof
    Patent number: 5698570
    Abstract: The present invention relates to a novel quinolone compound having an excellent antibacterial activity. More specifically, the present invention relates to a novel quinoline(naphthyridine)carboxylic acid derivative represented by the following formula (I), which has an 4-aminomethyl-3-oximepyrrolidine substituent on 7-position of the quinolone nucleus and shows a superior antibacterial activity in contrast to the known quinolone antibactrial agents having a weak activity against gram-positive bacterial strains and also has a broad antibacterial spectrum and a highly improved pharmacokinetic property: ##STR1## wherein R, R.sub.1, R.sub.2, R.sub.3, R.sub.4 and Q are defined as described in the specification.
    Type: Grant
    Filed: January 30, 1997
    Date of Patent: December 16, 1997
    Assignee: LG Chemical Ltd.
    Inventors: Chang Yong Hong, Young Kwan Kim, Jay Hyok Chang, Se Ho Kim, Hoon Choi, Do Hyun Nam, Jin Hwan Kwak, Yi Na Jeong, Jeong In Oh, Mu Yong Kim